HOPU Investments is an Asia-focused private equity firm headquartered in Hong Kong with additional offices in Beijing and Singapore. Founded in 2008, the firm specializes in large-scale proprietary investments including buyouts, carveouts, and strategic minority stakes across technology, logistics, consumer, and financial services sectors, with over $15 billion in assets under management.
Their most common stage is series-c (50% of deals). Average disclosed round size is $152.5M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
DC
Danhua Chen
Managing Director
HY
Hong Yu
Managing Director
KP
Ke Peng
Managing Director
CC
Cliff Chau
Partner
GH
Gunther Hamm
President
R(
Rebecca (Beike) Xu
Private Equity
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAmbrx Inc | Unknown | $45M | Nov 2020 |
| LLyndra Therapeutics Inc. | Series C | $55M | Jan 2019 |
| GG7 | Growth | $320M | Dec 2018 |
| II-Mab Biopharma | Series C | $220M | Jun 2018 |
| II-MAB | Series C | $220M | Jun 2018 |
| LLyndra | Series B | $55M | — |
Top Co-Investors
The Invus Group, LLC3 shared
EDBI2 shared
Ally Bridge Group2 shared
Gilead Sciences2 shared
Polaris Partners2 shared
Osney Capital1 shared
Cambridge Capital1 shared
Hillhouse Investment1 shared
CDH Investments1 shared
Staley Capital1 shared
Tencent Investment1 shared
GLP1 shared
Bank of China Group Investment1 shared
Gates Foundation1 shared
Bill & Melinda Gates Foundation1 shared
Maverick Ventures1 shared
Adage Capital Management1 shared
Apricot Capital1 shared
Suvretta Capital1 shared
Last updated: 8 September 2026